SAMANTHA VANVOORHIS: Open Payments
NPI 1649976416 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,661 in 211 payments from 29 companies in 2025. Trend: 2023 $2,209 · 2024 $4,712 · 2025 $8,661
Food & beverage: $5,097Consulting: $2,520Travel & lodging: $825Education: $219
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $3,920 |
| GlaxoSmithKline, LLC. | 38 | $627 |
| AstraZeneca Pharmaceuticals LP | 17 | $566 |
| JAZZ PHARMACEUTICALS INC. | 6 | $368 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $363 |
| Axsome Therapeutics, Inc. | 15 | $350 |
| Verona Pharma, Inc. | 12 | $304 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $242 |
| Actelion Pharmaceuticals US, Inc. | 7 | $229 |
| Insmed, Inc. | 10 | $219 |
Products named: DUPIXENT, XYWAV, NUCALA, Sunosi, Ohtuvayre, GLASSIA, FASENRA, AIRSUPRA.
Industry payments across CT — which companies pay providers there.
